EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF

Yogesh N V Reddy, Peter Noseworthy, Barry A Borlaug, Nancy M Albert

JACC: Heart Failure · 2024-06 · 12 (6) · 990-998

DOI: 10.1016/j.jchf.2024.04.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Heart Failure, 2024-06. Verfasst von Yogesh N V Reddy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: reddy.yogesh@mayo.edu. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Because of the bidirectional relationship between atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF), individuals with either condition require consideration of screening for the other. In this review, we summarize current evidence and rationale for screening for occult HFpEF in adults with clinical AF; and occult AF in patients with clinically recognized HFpEF. Assessment of pretest probability for occult HFpEF in symptomatic AF patients may help guide additional testing such as exercise right heart catheterization to diagnose HFpEF and guide HFpEF-specific therapies. In patients with HFpEF, AF screening will identify cases of occult AF where anticoagulation may decrease stroke risk, and correlation of previously unknown AF episodes with paroxysmal symptoms may prompt consideration for rhythm control. Therefore, screening may help clinicians understand the etiology of the often-overlapping symptoms, and it may help guide treatments to slow progression of both conditions and their complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureStroke VolumeHumansMass Screening

Stichwörter der Autor:innen

atrial fibrillationheart failure with preserved ejection fractionscreening

Autor:innen und Institutionen

  • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: reddy.yogesh@mayo.edu.
  • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
  • Cleveland Clinic Health System, Cleveland, Ohio, USA.

Förderung

  • NHLBI

Zitieren

APA

Reddy, Y. N. V., Noseworthy, P., Borlaug, B. A., & Albert, N. M. (2024). Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF. JACC: Heart Failure, 12(6), 990-998. https://doi.org/10.1016/j.jchf.2024.04.010

Vancouver

Reddy YNV, Noseworthy P, Borlaug BA, Albert NM. Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF. JACC: Heart Failure. 2024;12(6):990-998. doi:10.1016/j.jchf.2024.04.010

BibTeX
@article{Reddy2024,
  author = {Reddy, Yogesh N V and Noseworthy, Peter and Borlaug, Barry A and Albert, Nancy M},
  title = {Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF},
  journal = {JACC: Heart Failure},
  year = {2024},
  volume = {12},
  number = {6},
  pages = {990--998},
  doi = {10.1016/j.jchf.2024.04.010}
}
Kostenlos starten →